-
-
-
-
-
-
-
Nuvation Bio Inc. (NUVB) Reports In-Line Q1 EPS
-
-
-
-
-
-
-
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Nuvation Bio begins phase 3 trial of safusidenib for brain cancer
-
-
-
-
-
-
-
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Nuvation Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
-
1,216,202 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

